Computed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung disease
Main Article Content
Abstract
Background. Pulmonary hypertension (PH) after tuberculosis is increasingly recognised as important in high-burden tuberculosis settings. However, the ability of computed tomography (CT) imaging to accurately detect PH remains unclear.
Objectives. To evaluate the performance of standard CT measurements in detecting PH in patients with post-tuberculosis lung disease (PTLD), and to determine the potential role of CT imaging as a screening tool in this population.
Methods. A retrospective study of patients with PTLD was conducted from January 2019 to September 2021. Adult patients with both a CT chest scan and an echocardiogram performed within 9 months of each other were enrolled. A diagnosis of PH by echocardiography was made if the right ventricular systolic pressure (RVSP) was ≥36 mmHg or the peak tricuspid regurgitant jet velocity (TRVmax) >2.8 m/s. Radiological criteria for PH included a pulmonary artery/ascending aorta (PA/AA) diameter ratio >1, pulmonary artery diameter (PAD) ≥29 mm (males) or ≥27 mm (females), and right ventricle/left ventricle (RV/LV) diameter ratio ≥1.28. Spirometry was also performed.
Results. Of 173 patients with PTLD, 52 met the inclusion criteria. Significant correlations were found between the CT-measured PA/AA ratio and RVSP (p=0.0083) and TRVmax (p=0.0582), but not between the CT-measured RV/LV ratio and RVSP (p=0.1729) or TRVmax (p=0.0749). PAD was also significantly correlated with RVSP (p=0.0011) and TRVmax (p=0.0023). The PA/AA ratio identified patients with PH on echocardiography with ~100% sensitivity, 65% specificity and a positive predictive value of 39.1%, indicating a high potential for false-positive diagnosis. The forced vital capacity was 13.7% lower in patients with PH than in those without (p=0.044); however, the forced expiratory volume in 1 second was not statistically different.
Conclusion. A low PA/AA ratio can be used to rule out the diagnosis of PH in PTLD, but a high PA/AA ratio requires further investigation for PH.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. Thienemann F, Dzudie A, Mocumbi AO, et al. The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry. Int J Cardiol 2016;221:205-211. https://doi. org/10.1016/j.ijcard.2016.06.242
2. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016;37(1):67-119. https://doi. org/10.1093/eurheartj/ehv317
3. Gillenwater S, Martinez F, Drexler I, et al. Role of cardiovascular CT in pulmonary hypertension. Curr Radiol Rep 2020;8(8). https://doi.org/10.1007/s40134-020-00354-2
4. Subramanyam P, Abouzeid C, Groner LK. Multimodality imaging of pulmonary
hypertension. Curr Treat Options Cardiovasc Med 2020;22(11). https://doi.org/10.1007/
s11936-020-00843-9
5. Fukunaga R, Glaziou P, Harris JB, Date A, Floyd K, Kasaeva T. Epidemiology of tuberculosis and progress toward meeting global targets – worldwide, 2019. MMWR Morb Mortal Wkly Rep 2021;70(12):427-430. https://doi.org/10.15585/mmwr.mm7012a4
6. Allwood BW, Maarman GJ, Kyriakakis CG, Doubell AF. Post-pulmonary tuberculosis complications in South Africa and a potential link with pulmonary hypertension: Premise for clinical and scientific investigations. S Afr Med J 2018;108(7):529-529. https://doi.org/10.7196/SAMJ.2018.v108i7.13359.
7. Bhattacharyya P, Saha D, Bhattacherjee PD, Das SK, Bhattacharyya PP, Dey R. Tuberculosis associated pulmonary hypertension: The revelation of a clinical observation. Lung India 2016;33(2):135-139. https://doi.org/10.4103/0970- 2113.177433
8. Montani D, Günther S, Dorfmüller P, et al. Pulmonary arterial hypertension. Orphanet J Rare Dis 2013;8:97. https://doi.org/10.1186/1750-1172-8-97
9. Fakharian A, Hamidi N, Hosseinloo BH, et al. Correlation between the pulmonary artery pressure measured in echocardiography and pulmonary artery diameter in the CT-scan of patients suffering from interstitial lung disease. Tanaffos 2011;10(3):37-41.
10. Grünig E, Peacock AJ. Imaging the heart in pulmonary hypertension: An update. Eur Respir Rev 2015;24(138):653-664. https://doi.org/10.1183/16000617.0058-2015 11. Frost A, Badesch D, Gibbs JSR, et al. Diagnosis of pulmonary hypertension. Eur
Respir J 2019;53(1):1801904. https://doi.org/10.1183/13993003.01904-2018
12. Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT. CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest 2014;145(4):824-832. https://doi.org/10.1378/
chest.13-1422
13. Truong QA, Bhatia HS, Szymonifka J, et al. A four-tier classification system of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertension. J Cardiovasc Comput Tomogr 2018;12(1):60-66. https://doi.org/10.1016/j.jcct.2017.12.001
14. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: The ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999;14(4):270-278. https://doi.org/10.1097/00005382-199910000-00007
15. Greiner S, Jud A, Aurich M, et al. Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterisation: Analysis in a large patient population. J Am Heart Assoc 2014;3(4):e001103. https://doi.org/10.1161/JAHA.114.001103
16. QuanjerPH,StanojevicS,ColeTJ,etal.Multi-ethnicreferencevaluesforspirometry for the 3–95-yr age range: The global lung function 2012 equations. Eur Respir J 2012;40(6):1324-1343. https://doi.org/10.1183/09031936.00080312
17. Mahammedi A, Oshmyansky A, Hassoun PM, Thiemann DR, Siegelman SS. Pulmonary artery measurements in pulmonary hypertension. J Thorac Imaging 2013;28(2):96-103. https://doi.org/10.1097/RTI.0b013e318271c2eb
18. ZismanDA,KarlamanglaAS,RossDJ,etal.High-resolutionchestCTfindingsdonot predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;132(3):773-779. https://doi.org/10.1378/chest.07-0116
19. Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008;249(3):1042-1049. https://doi.org/10.1148/radiol.2492080269
20. Louw E, Baines N, Maarman G, et al. The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients. Pulm Circ 2023;13(1):e12184. https://doi.org/10.1002/pul2.12184
21. Chan AL, Juarez MM, Shelton DK, et al. Novel computed tomographic chest metrics to detect pulmonary hypertension. BMC Med Imaging 2011;11:7. https:// doi.org/10.1186/1471-2342-11-7
22. Altschul E, Remy-Jardin M, Machnicki S, et al. Imaging of pulmonary hypertension. Chest 2019;156(2):211-227. https://doi.org/10.1016/j.chest.2019.04.003
23. Bax S, Jacob J, Ahmed R, et al. Right ventricular to left ventricular ratio at CT pulmonary angiogram predicts mortality in interstitial lung disease. Chest 2020;157(1):89-98. https://doi.org/10.1016/j.chest.2019.06.033
24. Bax S, Bredy C, Dimopoulos K, et al. Right ventricular dimensions on CTPA predict pulmonary hypertension and prognosis in interstitial lung disease (ILD). ERS International Congress 2017 abstracts, published online September 2017. https:// doi.org/10.1183/1393003.congress-2017.PA2433
25. Ascha M, Renapurkar R, Tonelli AR. A review of imaging modalities in pulmonary hypertension. Ann Thorac Med 2017;12(2):61-73. https://doi.org/10.4103/1817- 1737.203742